title: Eukaryotic translation-initiation factor eIF2beta binds to protein kinase CK2: effects on CK2alpha activity.
abstract: eIF2 (eukaryotic translation-initiation factor 2) is a substrate and an interacting partner for CK2 (protein kinase CK2). Co-immuno-precipitation of CK2 with eIF2beta has now been observed in HeLa cells, overexpressing haemagglutinin-tagged human recombinant eIF2beta. A direct association between His6-tagged human recombinant forms of eIF2beta subunit and both the catalytic (CK2alpha) and the regulatory (CK2beta) subunits of CK2 has also been shown by using different techniques. Surface plasmon resonance analysis indicated a high affinity in the interaction between eIF2beta and CK2alpha, whereas the affinity for the association with CK2beta is much lower. Free CK2alpha is unable to phosphorylate eIF2beta, whereas up to 1.2 mol of phosphate/mol of eIF2beta was incorporated by the reconstituted CK2 holoenzyme. The N-terminal third part of eIF2beta is dispensable for binding to either CK2alpha or CK2beta, although it contains the phosphorylation sites for CK2. The remaining central/C-terminal part of eIF2beta is not phosphorylated by CK2, but is sufficient for binding to both CK2 subunits. The presence of eIF2beta inhibited CK2alpha activity on calmodulin and beta-casein, but it had a minor effect on that of the reconstituted CK2 holoenzyme. The truncated forms corresponding to the N-terminal or central/C-terminal regions of eIF2beta were much less inhibitory than the intact subunit. The results demonstrate that the ability to associate with CK2 subunits and to serve as a CK2 substrate are confined to different regions in eIF2beta and that it may act as an inhibitor on CK2alpha.
authors.affiliation: Departament de Bioquímica i Biologia Molecular, Unitat de Bioquímica de Ciències, Universitat Autònoma de Barcelona, Edifici Cs, Campus de Bellaterra, 08193 Bellaterra, Barcelona, Spain.
authors.forename: Franc
authors.initials: F
authors.lastname: Llorens
authors.forename: Nerea
authors.initials: N
authors.lastname: Roher
authors.forename: Francesc A
authors.initials: FA
authors.lastname: Miró
authors.forename: Stefania
authors.initials: S
authors.lastname: Sarno
authors.forename: F Xavier
authors.initials: FX
authors.lastname: Ruiz
authors.forename: Flavio
authors.initials: F
authors.lastname: Meggio
authors.forename: Maria
authors.initials: M
authors.lastname: Plana
authors.forename: Lorenzo A
authors.initials: LA
authors.lastname: Pinna
authors.forename: Emilio
authors.initials: E
authors.lastname: Itarte
mesh_terms: D000595:Amino Acid Sequence; D026481:Blotting, Far-Western; D002147:Calmodulin / Q000378:metabolism; D047390:Casein Kinase II; D002364:Caseins / Q000378:metabolism; D002460:Cell Line; D020717:Eukaryotic Initiation Factor-2B / Q000378:metabolism*; D006367:HeLa Cells; D006801:Humans; D007700:Kinetics; D008969:Molecular Sequence Data; D010766:Phosphorylation; D011485:Protein Binding; D017346:Protein Serine-Threonine Kinases / Q000235:genetics / Q000378:metabolism*; D021122:Protein Subunits / Q000378:metabolism; D011994:Recombinant Proteins / Q000378:metabolism; D013379:Substrate Specificity
chemical_list: D002147:Calmodulin; D002364:Caseins; D020717:Eukaryotic Initiation Factor-2B; D021122:Protein Subunits; D011994:Recombinant Proteins; D047390:Casein Kinase II; D017346:Protein Serine-Threonine Kinases